Literature DB >> 8889245

Organization of DNA topoisomerase II isotypes during the cell cycle of human lymphocytes and HeLa cells.

N Chaly1, X Chen, J Dentry, D L Brown.   

Abstract

We have monitored the organization of DNA topoisomerase II (Topo II) in relation to chromatin disaggregation during mitogen stimulation of lymphocytes and to the mitotic chromosome condensation cycle by immunofluorescence microscopy with isozyme-specific antibodies. Labelling for both Topo II alpha and Topo II beta was diffusely nucleoplasmic and non-nucleolar in resting lymphocytes and the pattern changed little during stimulation. Topo II alpha labelling intensity increased in parallel with the extent of cell stimulation, but a fraction of fully stimulated cells was labelled very brightly. Topo II beta labelling intensity was also greater in stimulated cells, but all partially and fully stimulated cells were labelled at the same, higher, intensity. In addition, anti-Topo II beta detected a few small spots within nucleoli of stimulated cells that coincided with regions containing fibrillarin. In lymphocytes and HeLa, chromosome association of Topo II alpha began in prophase and lasted throughout mitosis. In contrast, Topo II beta stayed nucleoplasmic in prophase, was diffusely cytoplasmic during mitosis, and was first detected post-mitotically in nuclei with decondensing chromosomes and a reformed nuclear envelope. The results are consistent with a role for Topo II alpha, but not for Topo II beta, in mitotic chromosome condensation, and indicate that the isotypes may play independent roles in the reorganization of chromatin structure during lymphocyte mitogenic activation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8889245     DOI: 10.1007/bf02265053

Source DB:  PubMed          Journal:  Chromosome Res        ISSN: 0967-3849            Impact factor:   5.239


  35 in total

1.  Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II.

Authors:  F H Drake; G A Hofmann; H F Bartus; M R Mattern; S T Crooke; C K Mirabelli
Journal:  Biochemistry       Date:  1989-10-03       Impact factor: 3.162

2.  Resolving the role of topoisomerase II in chromatin structure and function.

Authors:  L Poljak; E Käs
Journal:  Trends Cell Biol       Date:  1995-09       Impact factor: 20.808

3.  The 180-kDa isoform of topoisomerase II is localized in the nucleolus and belongs to the structural elements of the nucleolar remnant.

Authors:  N Zini; A M Martelli; P Sabatelli; S Santi; C Negri; G C Astaldi Ricotti; N M Maraldi
Journal:  Exp Cell Res       Date:  1992-06       Impact factor: 3.905

4.  The distribution of topoisomerase II on mammalian chromosomes.

Authors:  A T Sumner
Journal:  Chromosome Res       Date:  1996-01       Impact factor: 5.239

5.  Topoisomerase-II-mediated DNA cleavage within the human ribosomal genes.

Authors:  M Govoni; S Neri; T Labella; J E Sylvester; F Novello; A Pession
Journal:  Biochem Biophys Res Commun       Date:  1995-08-04       Impact factor: 3.575

Review 6.  The nucleolus.

Authors:  U Scheer; D Weisenberger
Journal:  Curr Opin Cell Biol       Date:  1994-06       Impact factor: 8.382

7.  Role of topoisomerase II in the structural and functional evolution of mitogen-stimulated lymphocyte nuclei.

Authors:  E Daev; N Chaly; D L Brown; B Valentine; J E Little; X Chen; P R Walker
Journal:  Exp Cell Res       Date:  1994-09       Impact factor: 3.905

8.  Changes in structure and composition of lymphocyte nuclei during mitogenic stimulation.

Authors:  G Setterfield; R Hall; T Bladon; J Little; J G Kaplan
Journal:  J Ultrastruct Res       Date:  1983-03

9.  In situ localization of DNA topoisomerase II, a major polypeptide component of the Drosophila nuclear matrix fraction.

Authors:  M Berrios; N Osheroff; P A Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

10.  The topoisomerase II inhibitor teniposide (VM-26) induces apoptosis in unstimulated mature murine lymphocytes.

Authors:  C Roy; D L Brown; J E Little; B K Valentine; P R Walker; M Sikorska; J Leblanc; N Chaly
Journal:  Exp Cell Res       Date:  1992-06       Impact factor: 3.905

View more
  13 in total

Review 1.  Topoisomerase II: untangling its contribution at the centromere.

Authors:  Andrew C G Porter; Christine J Farr
Journal:  Chromosome Res       Date:  2004       Impact factor: 5.239

Review 2.  The function of DNA topoisomerase IIβ in neuronal development.

Authors:  Xin Heng; Wei-Dong Le
Journal:  Neurosci Bull       Date:  2010-10       Impact factor: 5.203

3.  Depletion of topoisomerase IIalpha leads to shortening of the metaphase interkinetochore distance and abnormal persistence of PICH-coated anaphase threads.

Authors:  Jennifer M Spence; Hui Hui Phua; Walter Mills; Adam J Carpenter; Andrew C G Porter; Christine J Farr
Journal:  J Cell Sci       Date:  2007-10-23       Impact factor: 5.285

4.  Type II topoisomerase activities in both the G1 and G2/M phases of the dinoflagellate cell cycle.

Authors:  Carmen K M Mak; Victor K L Hung; Joseph T Y Wong
Journal:  Chromosoma       Date:  2005-11-15       Impact factor: 4.316

5.  NK314, a topoisomerase II inhibitor that specifically targets the alpha isoform.

Authors:  Eriko Toyoda; Shigehide Kagaya; Ian G Cowell; Aya Kurosawa; Keiichi Kamoshita; Kiyohiro Nishikawa; Susumu Iiizumi; Hideki Koyama; Caroline A Austin; Noritaka Adachi
Journal:  J Biol Chem       Date:  2008-07-02       Impact factor: 5.157

6.  Hypersensitivity of Ku-deficient cells toward the DNA topoisomerase II inhibitor ICRF-193 suggests a novel role for Ku antigen during the G2 and M phases of the cell cycle.

Authors:  P Muñoz; M Z Zdzienicka; J M Blanchard; J Piette
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

7.  Dynamics of human DNA topoisomerases IIalpha and IIbeta in living cells.

Authors:  Morten O Christensen; Morten K Larsen; Hans Ullrich Barthelmes; Robert Hock; Claus L Andersen; Eigil Kjeldsen; Birgitta R Knudsen; Ole Westergaard; Fritz Boege; Christian Mielke
Journal:  J Cell Biol       Date:  2002-04-01       Impact factor: 10.539

8.  Studying vertebrate topoisomerase 2 function using a conditional knockdown system in DT40 cells.

Authors:  Mark Johnson; Hui Hui Phua; Sophia C Bennett; Jennifer M Spence; Christine J Farr
Journal:  Nucleic Acids Res       Date:  2009-06-03       Impact factor: 16.971

9.  The α isoform of topoisomerase II is required for hypercompaction of mitotic chromosomes in human cells.

Authors:  Christine J Farr; Melissa Antoniou-Kourounioti; Michael L Mimmack; Arsen Volkov; Andrew C G Porter
Journal:  Nucleic Acids Res       Date:  2014-01-29       Impact factor: 16.971

10.  PTEN stabilizes TOP2A and regulates the DNA decatenation.

Authors:  Xi Kang; Chang Song; Xiao Du; Cong Zhang; Yu Liu; Ling Liang; Jinxue He; Kristy Lamb; Wen H Shen; Yuxin Yin
Journal:  Sci Rep       Date:  2015-12-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.